Analyzing the Industry 5. Adoption Barriers in the Pharmaceutical Sector Using an Integrated Fuzzy MCDM Methodology: A Case Study Application for Turkey

Basit Öğe Kaydı
dc.contributor.authorMaden, Ayca
dc.date.accessioned2025-03-09T10:49:06Z
dc.date.available2025-03-09T10:49:06Z
dc.date.issued2024
dc.departmentİstanbul Beykent Üniversitesi
dc.descriptionInternational Conference on Intelligent and Fuzzy Systems (INFUS) -- JUL 16-18, 2024 -- Istanbul Tech Univ, Canakkale, TURKEY
dc.description.abstractIndustry 5.0, emerging as a response to the mechanistic approach of Industry 4.0, seeks to integrate human-centric perspectives with advanced technologies to address global challenges. This transformative concept is reshaping sectors like pharmaceuticals, introducing novel manufacturing paradigms to meet evolving consumer demands. However, the pharmaceutical industry faces adoption barriers hindering its transition to Industry 5.0. This study analyses these barriers within the Turkish pharmaceutical sector using an integrated MCDM methodology. As a result of evaluations obtained from decision-makers, the use of fuzzy numbers was deemed necessary in this study. A key focus of this study involves applying the Fuzzy DEMATEL method to ascertain the significance of critical Industry 5.0 barriers. Additionally, the research expands its analysis by employing the EDAS method to prioritize the functions within a specific company. The EDAS method yielded the following ranking for the functions of the company: manufacturing, regulatory affairs, research and development, quality control and assurance, and sales and marketing. This research contributes to advancing Industry 5.0 implementation strategies, fostering innovation, and enhancing competitiveness within the pharmaceutical sector.
dc.description.sponsorshipCanakkale Onsekiz Mart Univ
dc.identifier.doi10.1007/978-3-031-67195-1_2
dc.identifier.endpage15
dc.identifier.isbn978-3-031-67194-4
dc.identifier.isbn978-3-031-67195-1
dc.identifier.issn2367-3370
dc.identifier.issn2367-3389
dc.identifier.scopus2-s2.0-85206995729
dc.identifier.scopusqualityQ4
dc.identifier.startpage8
dc.identifier.urihttps://doi.org/10.1007/978-3-031-67195-1_2
dc.identifier.urihttps://hdl.handle.net/20.500.12662/4728
dc.identifier.volume1089
dc.identifier.wosWOS:001329232000002
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorMaden, Ayca
dc.language.isoen
dc.publisherSpringer International Publishing Ag
dc.relation.ispartofIntelligent and Fuzzy Systems, Vol 2, Infus 2024
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250310
dc.subjectIndustry 5.0 barriers
dc.subjectDEMATEL
dc.subjectEDAS
dc.subjectpharmaceutical sector
dc.subjectFuzzy theory
dc.titleAnalyzing the Industry 5. Adoption Barriers in the Pharmaceutical Sector Using an Integrated Fuzzy MCDM Methodology: A Case Study Application for Turkey
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu